Study of the atopic march: Development of atopic comorbidities

Pediatric Dermatology

Volumn 33, Issue 4, 2016, Pages 388-398

  Schneider, Lynda ^a   Hanifin, Jon ^b   Boguniewicz, Mark ^c,d   Eichenfield, Lawrence F ^e   Spergel, Jonathan M ^f   Dakovic, Rada ^g   Paller, Amy S ^h  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e RADY CHILDREN'S HOSPITAL   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g MEDA Pharma GmbH and Co KG Biostatistics and Information   (Germany)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PIMECROLIMUS; PLACEBO;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BODY SURFACE; CAREGIVER; CHILD; COMORBIDITY; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; EARLY INTERVENTION; ECZEMA; FEMALE; FEVER; FOLLOW UP; FOOD ALLERGY; GASTROENTERITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; RHINORRHEA; SIDE EFFECT; SINUSITIS; STREPTOCOCCAL PHARYNGITIS; UPPER RESPIRATORY TRACT INFECTION; VIRAL GASTROENTERITIS; WHEEZING;

EID: 84978096877     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12867     Document Type: Article

References (21)

1. Shaw TE, Currie GP, Koudelka CW et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011;131:67–73.
2. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010;105:99–106.
3. Galli E, Gianni S, Auricchio G et al. Atopic dermatitis and asthma. Allergy Asthma Proc 2007;28:540–543.
4. Paul C, Cork M, Rossi AB et al. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years. Pediatrics 2006;117:e118–e128.
5. Sigurgeirsson B, Boznanski A, Todd G et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics 2015;135:597–606.
6. Kapp A, Papp K, Bingham A et al. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol 2002;110:277–284.
7. Ho VC, Gupta A, Kaufmann R et al. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr 2003;142:155–162.
8. Kaufmann R, Folster-Holst R, Hoger P et al. Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants. J Allergy Clin Immunol 2004;114:1183–1188.
9. Papp KA, Werfel T, Folster-Holst R et al. Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study. J Am Acad Dermatol 2005;52:240–246.
10. Eichenfield LF, Hanifin JM, Luger TA et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003;49:1088–1095.
11. Warner JO. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001;108:929–937.
12. ETAC Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. Pediatr Allergy Immunol 1998;9:116–124.
13. Thompson MM, Tofte SJ, Simpson EL et al. Patterns of care and referral in children with atopic dermatitis and concern for food allergy. Dermatol Ther 2006;19:91–96.
14. Leung DYM, Sampson HA, Geha RS et al. Pediatric Allergy—Principles and Practice, 2nd ed. St. Louis: Mosby, 2003.
15. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981;2:93–113.
16. Donner A. Approaches to sample size estimation in the design of clinical trials—a review. Stat Med 1984;3:199–214.
17. Stokes ME, Davis CS, Koch CG. Categorical Data Analysis Using the SAS System, 2nd ed. Cary, NC: SAS Institute, 2000.
18. van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007;120:565–569.
19. Kapoor R, Menon C, Hoffstad O et al. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 2008;58:68–73.
20. Bantz SK, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol 2014;5:202.
21. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003 Dec;112(6 Suppl):S118–S127.